
Innovations in Pharmaceutical Innovation A blog/ part-work from Mike Rea, exploring pharmaceutical innovation in general, and more specifically the approach to using the learning process for competitive advantage
| Platform | Pricing | Only free issues | Publishes | Twice weekly | |
|---|---|---|---|---|---|
| Issues | 348 | Founded | 6 years ago | Last Issue | 11 days ago |
| Active | |||||

Keytruda sold $31.7 billion in 2025. In early 2010, Merck had stopped developing it and was preparing to license it out. The antibody had been made at Organon, a Dutch company Schering-Plough bought in 2007, and arrived at Merck with the Sc...
In the spring of 1936, John Steinbeck left his setter puppy, Toby, alone for a night with the only handwritten draft of Of Mice and Men. By morning, roughly half of it was gone. There was no copy. Two months of work had to be done again.
H...
Fewer than one in ten molecules that enter Phase I reach approval. The figure has barely moved in two decades, despite better targets, better tools and much better money. Most of what we do still fails, and most of what we learn from it, we...
I’ve a quiet week this week - my wife’s away, my four dogs think it’s a walk every time I stand up, and I’ve no travel. So, I was left with a dog walk question after doing a lot of numbers posts recently…
Last week’s chart had a tidy answe...
Lipitor, the best-selling drug of its era and the subject of many case studies, made less than $1bn in its first 12 months on sale. In today’s money that is about $2bn. It is a useful floor to stand on, because the question of which drug ha...
Subscribers, engagement, traffic and sponsorship for Asymmetric Learning.
| Subscribers | Engagement | 73 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Was CEO, IDEA Pharma, now CEO, Then, If… Pharmaceutical innovation geek. Author: Pharmaceutical Positioning. My record label: Medical Records. Large, Geordie, dog fan, street-foodie
You can find recent issues that have been published by Asymmetric Learning on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Asymmetric Learning, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Asymmetric Learning as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Asymmetric Learning using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Asymmetric Learning. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.